Clinical

Clinical  ·  Weekly Digest 14 June to 20 June 2025
IDeate-Prostate01 Phase 3 trial of Ifinatamab Deruxtecan initiated in patients with pretreated metastatic castration-resistant prostate cancer

Weekly Digest – June 2025 Weekly Digest – June 2025 18 June 2025: IDeate-Prostate01 Phase 3 trial of Ifinatamab Deruxtecan initiated in patients with pretreated metastatic castration-resistant prostate cancer The IDeate-Prostate01 Phase 3 trial has begun, evaluating Ifinatamab deruxtecan (I-DXd) […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 14 June to 20 June 2025
Debiopharm’s ADC research gains momentum with launch of first-in-human trial assessing Debio 1562M in acute myeloid leukemia patients

Weekly Digest – June 2025 Weekly Digest – June 2025 16 June 2025: Debiopharm’s ADC research gains momentum with launch of first-in-human trial assessing Debio 1562M in acute myeloid leukemia patients Debiopharm has dosed the first patient in a Phase […]

by Sandhya Ramalingam

Continue Reading